EVIDENCE THAT THE RISKS OF MISOPROSTOL OUTWEIGH ITS BENEFITS IN STABLE CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS
被引:0
|
作者:
WILKIE, ME
论文数: 0引用数: 0
h-index: 0
机构:
ROYAL LONDON HOSP,LONDON HOSP MED CTR,DEPT CLIN BIOCHEM,LONDON E1 2AD,ENGLANDROYAL LONDON HOSP,LONDON HOSP MED CTR,DEPT CLIN BIOCHEM,LONDON E1 2AD,ENGLAND
WILKIE, ME
[1
]
BEER, JC
论文数: 0引用数: 0
h-index: 0
机构:
ROYAL LONDON HOSP,LONDON HOSP MED CTR,DEPT CLIN BIOCHEM,LONDON E1 2AD,ENGLANDROYAL LONDON HOSP,LONDON HOSP MED CTR,DEPT CLIN BIOCHEM,LONDON E1 2AD,ENGLAND
BEER, JC
[1
]
NEWMAN, D
论文数: 0引用数: 0
h-index: 0
机构:
ROYAL LONDON HOSP,LONDON HOSP MED CTR,DEPT CLIN BIOCHEM,LONDON E1 2AD,ENGLANDROYAL LONDON HOSP,LONDON HOSP MED CTR,DEPT CLIN BIOCHEM,LONDON E1 2AD,ENGLAND
NEWMAN, D
[1
]
RAFTERY, MJ
论文数: 0引用数: 0
h-index: 0
机构:
ROYAL LONDON HOSP,LONDON HOSP MED CTR,DEPT CLIN BIOCHEM,LONDON E1 2AD,ENGLANDROYAL LONDON HOSP,LONDON HOSP MED CTR,DEPT CLIN BIOCHEM,LONDON E1 2AD,ENGLAND
RAFTERY, MJ
[1
]
MARSH, FP
论文数: 0引用数: 0
h-index: 0
机构:
ROYAL LONDON HOSP,LONDON HOSP MED CTR,DEPT CLIN BIOCHEM,LONDON E1 2AD,ENGLANDROYAL LONDON HOSP,LONDON HOSP MED CTR,DEPT CLIN BIOCHEM,LONDON E1 2AD,ENGLAND
MARSH, FP
[1
]
机构:
[1] ROYAL LONDON HOSP,LONDON HOSP MED CTR,DEPT CLIN BIOCHEM,LONDON E1 2AD,ENGLAND